{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:46:33Z","timestamp":1761821193410},"reference-count":30,"publisher":"FapUNIFESP (SciELO)","issue":"2A","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:p>We report on two epileptic patients who developed acute psychosis after the use of topiramate (TPM). One patient exhibited severe psychomotor agitation, heteroaggressiveness, auditory and visual hallucinations as well as severe paranoid and mystic delusions. The other patient had psychomotor agitation, depersonalization, derealization, severe anxiety and deluded that he was losing his memory. Both patients had to be taken to the casualty room. After interruption of TPM in one patient and reduction of dose in the other, a full remission of the psychotic symptoms was obtained without the need of antipsychotic drugs. Clinicians should be aware of the possibility of development of acute psychotic symptoms in patients undergoing TPM treatment.<\/jats:p>","DOI":"10.1590\/s0004-282x2002000200019","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T10:30:55Z","timestamp":1113561055000},"page":"285-287","source":"Crossref","is-referenced-by-count":24,"title":["Acute psychotic disorders induced by topiramate: report of two cases"],"prefix":"10.1590","volume":"60","author":[{"given":"Florindo","family":"Stella","sequence":"first","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorgival","family":"Caetano","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Cendes","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.M.","family":"Guerreiro","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"Suppl 2","key":"ref1","first-page":"122","article-title":"The novel anticonvulsant topiramate enhances GABA-mediated chloride flux (Abstract)","volume":"34","author":"Brown SD","year":"1993","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1528-1157.1996.tb00606.x","article-title":"Double-blind, placebo- controlled trial of topiramate as add-on therapy in patients with refractory partial seizures","volume":"37","author":"Ben-Menachem E","year":"1996","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref3","first-page":"1684","article-title":"The topiramate YD Study Group","volume":"46","author":"Faught E","year":"1996","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/106002809703101010","article-title":"Topiramate: a new antiepileptic drug","volume":"31","author":"Privitera MD","year":"1997","journal-title":"Ann Pharmacother","ISSN":"http:\/\/id.crossref.org\/issn\/1060-0280","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1157.1997.tb04518.x","article-title":"Preliminary open-label experience with topiramate in primary generalized seizures","volume":"38","author":"Biton V","year":"1997","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1528-1157.1997.tb04515.x","article-title":"Topiramate as adjunctive therapy in refractory partial epilepsy: pooled analysis data from five double-blind, placebo-controlled trials","volume":"38","author":"Reife RA","year":"1997","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0165-0327(98)00110-4","article-title":"Use of topiramate, a new anti-epileptic , as a mood stabilizer","volume":"50","author":"Marcotte D","year":"1998","journal-title":"J Affect Disord","ISSN":"http:\/\/id.crossref.org\/issn\/0165-0327","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0006-3223(99)00316-9","article-title":"Open-label adjunctive topiramate in the treatment of bipolar disorders","volume":"47","author":"McElroy SL","year":"2000","journal-title":"Biol Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0006-3223","issn-type":"print"},{"key":"ref9","first-page":"13","article-title":"Update on the use of topiramate in bipolar disorder (Abstract)","volume":"44A","author":"Calabrese JR","year":"2000","journal-title":"Am Psychiat Assoc"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1528-1157.1996.tb06029.x","article-title":"Safety of topiramate: adverse events and relationships to dosing","volume":"37","author":"Shorvon SD","year":"1996","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref11","first-page":"64","article-title":"Severe psychiatric reactions to topiramate","volume":"38","author":"Betts T","year":"1997","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1528-1157.1997.tb04516.x","article-title":"Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment","volume":"38","author":"Rosenfeld WE","year":"1997","journal-title":"Epilepsy","ISSN":"http:\/\/id.crossref.org\/issn\/0141-965X","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1528-1157.1997.tb04521.x","article-title":"Practical aspects of the use of topiramate in patients with epilepsy","volume":"38","author":"Sander JWAS","year":"1997","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1528-1157.1998.tb01919.x","article-title":"Anticonvulsivant-related psychoses in epilepsy","volume":"39","author":"Matsuura M","year":"1998","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/jnnp.66.6.759","article-title":"Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic","volume":"66","author":"Kellet MW","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry","ISSN":"http:\/\/id.crossref.org\/issn\/0022-3050","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.52.2.321","article-title":"Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults","volume":"52","author":"Martin R","year":"1999","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1528-1157.2000.tb00322.x","article-title":"A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures","volume":"41","author":"Aldenkamp AP","year":"2000","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1528-1157.2000.tb02175.x","article-title":"Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults","volume":"41","author":"Reife R","year":"2000","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1059-1311(98)80037-X","article-title":"An audit of topiramate use in a general neurology clinic","volume":"7","author":"Crawford P","year":"1998","journal-title":"Seiz Eur J Epilep"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/seiz.1999.0287","article-title":"Acute psychotic symptoms induced by topiramate","volume":"84","author":"Khan A","year":"1999","journal-title":"Seizure","ISSN":"http:\/\/id.crossref.org\/issn\/1059-1311","issn-type":"print"},{"key":"ref21","first-page":"207","article-title":"Neuropsychiatric profile of high-dose topiramate","volume":"38","author":"Abou-Khalil B","year":"1997","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref22","first-page":"97","article-title":"Acute psychotic symptoms induced by topiramate","volume":"38","author":"Khan A","year":"1997","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/seiz.2000.0405","article-title":"Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables","volume":"9","author":"Trimble MR","year":"2000","journal-title":"Seizure","ISSN":"http:\/\/id.crossref.org\/issn\/1059-1311","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00003088-199324060-00002","article-title":"Comparative pharmacokinetics of the newer antiepileptic drugs","volume":"24","author":"Bialer M","year":"1993","journal-title":"Clin Pharmacokinet","ISSN":"http:\/\/id.crossref.org\/issn\/0312-5963","issn-type":"print"},{"key":"ref25","first-page":"114","article-title":"Medication of the month: topiramate (topamax)","volume":"55","author":"Sadzot B.","year":"2000","journal-title":"Rev Med Liege","ISSN":"http:\/\/id.crossref.org\/issn\/0035-3663","issn-type":"print"},{"key":"ref26","first-page":"32","article-title":"Current data on topiramate","volume":"30","author":"Herranz JL","year":"2000","journal-title":"Rev Neurol","ISSN":"http:\/\/id.crossref.org\/issn\/0210-0010","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003088-199631030-00004","article-title":"Clinically significant pharmacokinetic drug interactions with carbamazepine: an update","volume":"31","author":"Spina E","year":"1996","journal-title":"Clin Pharmacokinet","ISSN":"http:\/\/id.crossref.org\/issn\/0312-5963","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1528-1157.1996.tb06028.x","article-title":"Drug interaction profile of topiramate","volume":"37","author":"Bourgeois BF","year":"1996","journal-title":"Epilepsia","ISSN":"http:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref29","series-title":"Psychotropic Drug Directory 2000: The professionals' pocket handbook and aide memoire","first-page":"257","author":"Bazire S.","year":"2000"},{"key":"ref30","series-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","year":"1992"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v60n2a\/a19v60n2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T17:41:45Z","timestamp":1495647705000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2002000200019&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":30,"journal-issue":{"issue":"2A","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S0004-282X2002000200019"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2002000200019","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}